3,4-Dihydroquinazoline-2(1H)-thione

Catalog No.: 
ACBGCF531
CAS No.: 
22820-08-2
Molecular Formula: 
C8H8N2S
Molecular Weight: 
164.23
3,4-Dihydroquinazoline-2(1H)-thione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg90%$57.00In stockIn stock
250mg90%$97.00In stockIn stock
1g90%$259.00In stockInquiry
5g90%$1256.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,4-Dihydroquinazoline-2(1H)-thione
IUPAC Name3,4-dihydroquinazoline-2(1H)-thione
MDL No.MFCD01648728
Molecular FormulaC8H8N2S
Molecular Weight164.23
SMILESS=C1NC2=C(C=CC=C2)CN1
InChI KeyVGNAMTKXQSLQJZ-UHFFFAOYSA-N
Synonym2(1H)-Quinazolinethione,3,4-dihydro-;3,4-dihydro-1H-quinazoline-2-thione;3,4-Dihydroquinazoline-2(1H)-thione;3,4-Dihydro-2(1H)-quinazolinethione
CAS No.22820-08-2
PubChem CID3644854

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H315-H318-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBGCF531 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOPAJ032 route compound structure diagram
    ACOPAJ0324403-69-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBGCF531 route product structure diagram
    ACBGCF53122820-08-2In Stock
Inquiry

2. ACBGCF531 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBGCF531 route product structure diagram
    ACBGCF53122820-08-2In Stock
Inquiry

3. ACBGCF531 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBGCF531 route product structure diagram
    ACBGCF53122820-08-2In Stock
Inquiry

Comments (0)